Allergy Diagnostics and Treatment Market by Diagnostic Tests (Skin Prick Test, Intradermal, Patch Test, and In Vitro), Drug Class (Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics Immunomodulators, Autoinjectable Epinephrine, and Immunotherapy), Product Type (Instruments, Consumables, and Services), Allergen Type (Food, Inhaled, Drug, and Others), End User (Diagnostic Laboratories, Hospitals, and Academic Research Institutes) and Geography: Global Market Size Estimates and Forecast (2022-2030)

The market crossed the US$ 5.48 billion mark in 2022 and is expected to hit US$ 10.92 billion by 2030, recording a CAGR of 9.0% during the forecast period.

The allergy diagnostics and treatment market has grown significantly due to rising incidence and the need for allergy treatment.

The growing prevalence of allergic disorders demands allergy immunotherapy, a safe and effective treatment against allergens such as pollen, insect molds, animals, and allergic asthma. As per the data of the National Center for Health Statistics survey carried out in 2018, the number of reported respiratory, food, and skin allergies in the past 12 months was 7.1 million, 4.8 million, and 9.2 million, respectively. Thus, the market is expected to witness substantial growth during the forecast period. In 2021, the consumables segment by product type was likely to pace with the rising adoption as the cases of rising allergies and the need for rapid tests involved in diagnosing the allergic conditions.

Within the report, the market is segmented into diagnostics test, drug class, product type, allergan type, end user, and geography. By diagnostics test, the global allergy diagnostics and treatment market is segmented into skin prick test, intradermal, patch test, and in vitro. The allergy diagnostics and treatment market is segmented by drug class into antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anticholinergics immunomodulators, autoinjectable epinephrine, and immunotherapy. Based on product type, the allergy diagnostics and treatment market is segmented into instruments, consumables, and services. By allergan type, the global allergy diagnostics and treatment market is segmented into food, inhaled, drug, and others. Based on the end user, the global allergy diagnostics and treatment market is segmented into diagnostic laboratories, hospitals, and academic research institutes. Geographically, the market is sub-segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

Get more information on this report : Request Free Sample PDF

In vitro segment hold the largest market share by diagnostic tests.

Allergy is a hypersensitive immune reaction where an external, harmless substance is causing pathology. Allergic reactions significantly affect the health of the patient. In the US, allergies are the 6^th leading chronic illness with an annual cost above the US $18 billion. The constant need for minimally invasive detection of allergies and increasing pollution-related allergies will accelerate the demand for in-vitro allergy tests.

Rising adoption due to the use of eHealth in allergy diagnostics is one of the major factors accelerating market growth.

The technological developments have enabled players to integrate the internet of things (IoT) with medical devices, facilitating the connection between patients and service providers. The built-in connectivity for allergy diagnostics devices through mobile applications, cloud, machine-to-machine, and other options has resulted in adopting of telemedicine and eHealth technologies. Current advancements, such as integrating wireless communication and biosensors produce innovative devices for patients. Several apps have been developed that help to monitor and control allergies. For instance, Allergymonitor monitors medicine consumption and symptoms. Thus, the developments have allowed medical device players to attract the population to offer their innovative medical devices. Moreover, eHealth is a rapidly expanding field of medicine and an alternative method for delivering quality medical care to patients, who now have various healthcare services at their fingertips. With the COVID-19 pandemic, there has been an increase in the use of telemedicine to connect patients and healthcare providers, which has been made possible by mobile health (mHealth) applications.

Recent strategic developments in allergy diagnostics and treatment market

The allergy diagnostics and treatment market has undergone several significant developments, and a few of these have been mentioned below:

• In January 2020, Aimmune Therapeutics, Inc. received FDA approval for Palforzia, the first drug for the treatment of peanut allergy in children.
• In August 2018, the United States Food and Drug Administration (USFDA) granted Breakthrough Therapy designation to Xolair to prevent severe allergic reactions caused due to accidental exposure to one or more foods in patients with allergies.

Several players drive the allergy diagnostics market by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. bioMerieux; Thermo Fisher Scientific; Danaher Corporation; Stallergenes Greer; Hitachi Chemical Diagnostics; Siemens Healthcare; Omega Diagnostics; Hycor Biomedical; Lincoln Diagnostics; HOB Biotech Group Suzhou Co., Ltd are among the prominent players operating in the market.

Target audience for the report:

• Raw material providers
• Allergy diagnostics-related service providers
• Allergy-related associations, organizations, forums, and alliances
• Government bodies, such as regulating authorities and policymakers
• Venture capitalists, private equity firms, and start-up companies
• Allergy diagnostics panel and devices distributors and sales firms
• End users
• Research institutes, organizations, and consulting companies

Scope of the report:

In this report, the market has been segmented on the basis of:

• Diagnostic Tests:
  • Skin Prick Test
  • Intradermal
  • Patch Test
  • In Vitro
• Drug Class
  • Antihistamines
  • Decongestants
  • Corticosteroids
  • Mast Cell Stabilizers
  • Leukotriene Inhibitors
  • Nasal Anticholinergics Immunomodulators
  • Autoinjectable Epinephrine
  • Immunotherapy
• Product Type:
  • Instruments
  • Consumables
  • Services
• Allergen Type:
  • Food
  • Inhaled
  • Drug
  • Others
• End User:
  • Diagnostic Laboratories
  • Hospitals
  • Academic Research Institutes
• Region
  • North America
  • Europe
  • Asia Pacific (APAC)
  • South & Central America
  • Middle East & Africa
• Companies profiled
  • bioMerieux
  • Thermo Fisher Scientific
  • Danaher Corporation
  • Stallergenes Greer
  • Hitachi Chemical Diagnostics
  • Siemens Healthcare
  • Omega Diagnostics
  • Hycor Biomedical
  • Lincoln Diagnostics
  • HOB Biotech Group Suzhou Co., Ltd